Cash & equivalents increased 43.9%
Cash & equivalents changed +43.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +43.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Net income changed +24.9% from the comparable as-filed period.
Operating margin changed +151 basis points from the comparable as-filed period.
Gross margin changed +220 basis points from the comparable as-filed period.
Operating income changed +14.3% from the comparable as-filed period.
Inventory / revenue changed +268 basis points from the comparable as-filed period.
Revenue changed +5.4% from the comparable as-filed period.
Inventory changed +9.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross profit changed +11.6% from the comparable as-filed period.
Research & development changed +7.9% from the comparable as-filed period.
Debt changed -0.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.